CIRI Oncology Research Alliance

CIRI肿瘤研究联盟

• 批准号: 10674782
• 负责人: Shahzad Siddique
• 金额: $ 93.23万
• 依托单位: COMMONSPIRIT HEALTH RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10674782
• 关键词: Acceleration; Access to Information; Address; Adoption; Cancer Center; Cancer Control; Cancer Research Network; Caring; Clinical Research; Clinical Trials; Collection; Communities; Community Hospitals; Community Networks; Community Outreach; Consent Forms; Country; Cultural Sensitivity; Data; Databases; Detection; Disease; Electronic Health Record; Enrollment; Evaluation; Feeds; Geography; Goals; Growth; Health; Health system; Human; Informed Consent; Infrastructure; Institutional Review Boards; Leadership; Legal; Malignant Neoplasms; Modeling; National Cancer Institute; Nurses; Oncologist; Oncology; Patients; Patterns of Care; Physicians; Population; Population Heterogeneity; Positioning Attribute; Prevention; Process; Quality of life; Research; Research Institute; Research Personnel; Research Support; Resources; Rural; Service delivery model; Services; Site; Standardization; Structure; Study Subject; System; Training; Translating; Translations; Underrepresented Populations; Work; anticancer research; barrier to care; cancer care; cancer clinical trial; cancer prevention; care delivery; community based research; community setting; data warehouse; design; ethnic minority; human subject; improved; innovation; multidisciplinary; participant enrollment; patient navigation; patient screening; personalized medicine; programs; quality assurance; racial minority; recruit; research study; response; screening; survivorship; symposium; tumor; tumor registry

PROJECT SUMMARY/ABSTRACT The Catholic Health Initiatives’ (CHI) Institute for Research and Innovation (CIRI) Oncology Research Alliance (CORA) seeks to continue to support and expand a community-based cancer research network, currently across nine states, made up of community hospitals and cancer centers and incorporate best practices in enrolling patients to National Cancer Institute (NCI)-sponsored cancer control, prevention, and care delivery clinical trials and other human subjects’ studies. The specific aims are: to the increase enrollment in cancer control, prevention and care delivery clinical trials by providing access to a wide portfolio of high quality research studies that meet the needs of CORA’s diverse populations, annually accruing 10% of new cancer cases within the populations served by the network; identify, design and implement cancer care delivery research (CCDR) that leads to improved models of care and translates to high quality, value-based services throughout the oncology continuum; and expand efforts to explore and address the cancer care needs of racial and ethnic minorities as well as other underrepresented populations. Applying CIRI’s innovative, centralized and standardized organizational research model encompassing a network of geographically diverse community cancer programs, CIRI will continue to provide the necessary resources for amplifying clinical trials across the country. CORA’s geographic reach and involvement with diverse Primary and Sub-Affiliates allow it to offer a wide portfolio of trials to large, established programs as well as small, rural sites and new regions that historically have had limited access to cancer clinical trials. Applying best practices from CORA to all current and new Primary and Sub-Affiliates along with increased physician engagement will increase the number of patients screened and enrolled in clinical trials. Leveraging CHI’s unique, well-positioned standard oncology electronic health records (OEHR), enterprise data warehouse, and analytics capability will continue to give CORA the depth of data and access to information needed to expand CCDR. CHI's OEHR at CORA sites yield accessible data across the network that feeds into the data warehouse. CHI’s single network tumor registry database and OEHR make CORA responsive to requests for data around patterns of care. Lastly, the advanced patient navigation, survivorship, and multidisciplinary conferences and disease site specific tumor boards already in place at all Primary and Sub-Affiliate sites will support this research. Expanding to additional health systems and sites, and adding new investigators as opportunities arise will increase the number of patients from underrepresented populations that CORA can screen for enrollment in cancer clinical trials. CORA Primary and Sub-Affiliates’ community outreach coordinators’ and navigators’ integrated efforts will be utilized to improve cancer control and prevention, detection, care delivery, and treatment for these populations. Continued growth of CORA’s community partner networks, cultural sensitivity, translation support and nurse navigation training at all Primary and Sub-Affiliate sites will help eliminate barriers to care.

项目概要/摘要 天主教健康倡议 (CHI) 研究与创新研究所 (CIRI) 肿瘤学研究联盟 （CORA）寻求继续支持和扩大基于社区的癌症研究网络，目前 横跨九个州，由社区医院和癌症中心组成，并将最佳实践纳入 将患者纳入国家癌症研究所 (NCI) 赞助的癌症控制、预防和护理服务 临床试验和其他人类受试者研究的具体目标是：增加癌症患者的入学率。 通过提供广泛的高质量组合来控制、预防和护理提供临床试验 满足 CORA 不同人群需求的研究，每年增加 10% 的新癌症 网络服务人群中的病例识别、设计和实施癌症护理服务； 研究 (CCDR) 可改进护理模式并转化为高质量、基于价值的服务 整个肿瘤学连续体；并扩大努力探索和满足种族的癌症护理需求 少数民族以及其他代表性不足的人群。 标准化的组织研究，对地理上不同的网络进行建模 CIRI将继续为扩大临床试验提供必要的资源 CORA 的地理覆盖范围以及与不同主要附属机构和附属附属机构的参与使其得以实现。 为大型、已建立的项目以及小型、农村地点和新地区提供广泛的试验组合 历史上，将 CORA 的最佳实践应用于所有当前的癌症临床试验的机会有限。 新的主要附属机构和附属附属机构以及医生参与度的增加将增加 利用 CHI 独特、定位良好的标准肿瘤学筛选患者并参加临床试验。 电子健康记录（OEHR）、企业数据仓库和分析能力将继续提供 CORA 扩展 CORA 站点的 CCDR CHI OEHR 所需的数据深度和信息访问。 通过网络访问数据并输入 CHI 的单一网络肿瘤登记处。 数据库和 OEHR 使 CORA 能够响应有关护理模式的数据请求。 先进的患者导航、生存、多学科会议和疾病部位特定肿瘤 所有主要和附属机构站点已设立的委员会将支持这项研究。 卫生系统和场所，并在机会出现时增加新的调查员将增加 CORA 可以筛选来自代表性不足人群的患者，以纳入癌症临床试验。 CORA 主要和次级附属机构的社区外展协调员和导航员的综合努力将 用于改善这些人群的癌症控制和预防、检测、护理提供和治疗。 CORA 社区合作伙伴网络、文化敏感性、翻译支持和护士的持续发展 所有主要和附属机构站点的导航培训将有助于消除护理障碍。